This site is intended for healthcare professionals only

Issue:

Early View

Tandem system significantly increases time-in-range in young people

Devices – October 2019 digest

Dramatic increases in time-in-range without increased hypoglycaemia during exercise in children and adolescents using t:slim X2 Control-IQ.

Use of the t:slim X2 Control-IQ hybrid closed-loop system dramatically increased time-in-range (TiR) without increasing hypoglycaemia in a study of children and adolescents participating in high levels of exercise. TiR increased by almost 4 hours in a group of 12- and 17-year-olds participating in a 3-day skiing trip during which they spent about 5 hours on the ski slopes each day. 

There was a significant difference in the increased TiR between the two age groups, according to Dr Boris Kovatchev who presented the study findings on day 2 of the EASD conference. On average, the children spent 30 minutes more TiR; whereas the adolescents spent a staggering 5.6 hours more per day within the 3.9–7.8 mmol/L (70–140 mg/dl) range. The reason for this difference is not completely understood but Dr Kovatchev speculated that the teenagers might have spent more time in closed loop.

After participating in the ski camp, 24 young people continued to use the Tandem closed-loop system for a further 3 days at home. During this time, their TiR improved from 53% to 71%, equating to an additional 4.4 hours in range. This improvement did not result in an increase in time spent in hypoglycaemia. 

These findings reflect the results of the International Diabetes Closed Loop Protocol-3 study, in which TiR was 71% with Control-IQ technology compared to 59% in those using sensor-augmented pump therapy alone. Participants, who were aged at least 14 and had type 1 diabetes, also spent significantly less time in hypo- and hyperglycaemia and had statistically significant improvements in HbA1c and reductions in mean blood glucose.

Related content
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.